IDEXX stock price target raised to $530 at BTIG
BTIG analyst Mark Massaro announced an increased price target for IDEXX Laboratories (NASDAQ:IDXX), raising it from $500 to $530, while maintaining a Buy rating on the stock. The revision follows ...
TMCnet14h
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
BTIG is a leading global financial services firm specializing in investment banking, institutional trading, research, and ...
DraftKings price target raised to $59 from $55 at BTIG
BTIG analyst Clark Lampen raised the firm’s price target on DraftKings (DKNG) to $59 from $55 and keeps a Buy rating on the shares as part of a ...
BTIG Keeps Their Buy Rating on DraftKings (DKNG)
In a report released today, Clark Lampen from BTIG maintained a Buy rating on DraftKings (DKNG – Research Report), with a price target of ...
BTIG Research Estimates D.R. Horton’s Q4 Earnings (NYSE:DHI)
Research analysts at BTIG Research reduced their Q4 2025 earnings estimates for shares of D.R. Horton in a research note ...
Deckers Outdoor remains defensive, CFO warns of FX headwinds
Deckers Outdoor stock falls 14% as raised guidance falls short of expectations, facing headwinds from strong dollar and ...
BTIG maintains neutral PayPal stock rating amid growth concerns
BTIG analyst Lance Jessurun reaffirmed a Neutral rating on PayPal (NASDAQ:PYPL) stock, expressing caution ahead of the ...